FDA Inspection 1330852 — Ruffo De Freitas Junior, MD, PhD
The FDA completed an inspection of Ruffo De Freitas Junior, MD, PhD on Jul 24, 2026 in Goiania. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 24, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Goiania (Brazil)
Additional Details
Clinical Investigator (CI)